Biogen’s RoActemra Biosimilar Begins EU Approvals Process
The BIIB800 Candidate Is Only the Latest Of Biogen’s Deal-Driven Biosimilars
The European Medicines Agency has accepted Biogen’s marketing authorization submission for its BIIB800, developed by Chinese firm Bio-Thera.
